If you’re looking for MS care in California, you’ll find a range of centers across the state from major Los Angeles clinics to regional programs in Northern and Southern California. Use this guide to compare options like Cedars-Sinai Multiple Sclerosis Clinic, Mercy Multiple Sclerosis Center, PAMF Multiple Sclerosis Center, and others so you can choose the program that best matches your needs and location.
29 MS treatment centers68 active clinical trialsTop centers include Cedars-Sinai and PAMF5 providers with Medicare prescribing data
Center types in California
Academic MS Center (10)
Dedicated MS Practice (7)
Community Hospital Program (5)
Regional Neurology Group (4)
Boutique MS Practice (3)
Filter by type:
Centers with Most Active Trials in California
Ranked by active clinical trial count from ClinicalTrials.gov. Not a quality ranking.
1. UCSF Multiple Sclerosis Center23 trials
3. UC San Diego Health MS Program10 trials
Largest Care Teams in California
3. The Neurology Group1 provider
MS Care by City
Active MS clinical trials in California
See all 67 MS trials in California →ActivePhase 3
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
Hoffmann-La Roche
Irvine · Stanford
ActivePhase 4
A Multicenter Study of Continued Current Therapy vs Transition to Ofatumumab After Neurofilament (NfL) Elevation
Novartis Pharmaceuticals
Torrance
ActivePhase 3
Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis
Novartis Pharmaceuticals
Los Angeles
ActivePhase 3
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
Hanford · Los Angeles · +1
ActivePhase 4
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis
Novartis Pharmaceuticals
San Francisco
ActivePhase 3
A Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Ocrelizumab in Adult Participants With Primary Progressive Multiple Sclerosis
Hoffmann-La Roche
Berkeley · Fullerton · +1
ActivePhase 3
Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Novartis Pharmaceuticals
Berkeley · Fullerton · +4
ActivePhase 3
Study to Evaluate the Efficacy and Safety of Fenebrutinib Compared With Teriflunomide in Relapsing Multiple Sclerosis (RMS)
Hoffmann-La Roche
Torrance






















